News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rolfe Lindsey
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| Rolfe Lindsey (Director) has filed a Form 4 on Atreca, Inc.|
Txns:
| Granted 12,000 options to buy
@ $1.18, valued at
$14.2k
|
|
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2022 |
4
| Rolfe Lindsey (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Sold 2,545 shares
@ $1.2, valued at
$3.1k
Exercised 5,063 restricted stock units
@ $0 |
|
| 08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Rolfe Lindsey (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Sold 1,884 shares
@ $4.55, valued at
$8.6k
Sold 2,325 shares
@ $4.55, valued at
$10.6k
Exercised 3,749 restricted stock units
@ $0
Exercised 4,625 restricted stock units
@ $0 |
|
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| Rolfe Lindsey (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Sold 1,728 shares
@ $5.68, valued at
$9.8k
Exercised 3,438 restricted stock units
@ $0 |
|
| 12/16/2020 |
4
| Rolfe Lindsey (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Paid exercise price by delivering 14,153 shares
@ $5.11, valued at
$72.3k
Exercised 17,241 options to buy
@ $3.28, valued at
$56.6k
|
|
| 12/07/2020 |
4
| Rolfe Lindsey (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Sold 315 shares
@ $4.89, valued at
$1.5k
Sold 346 shares
@ $4.89, valued at
$1.7k
Exercised 625 restricted stock units
@ $0
Exercised 687 restricted stock units
@ $0 |
|
| 11/05/2020 |
4
| Rolfe Lindsey (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Sold 1,920 shares
@ $4.93, valued at
$9.5k
Exercised 3,749 restricted stock units
@ $0 |
|
| 09/23/2020 |
4
| Rolfe Lindsey (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Sold 21 shares
@ $6.86, valued at
$144.1
Sold 1,726 shares
@ $6.85, valued at
$11.8k
Exercised 3,437 restricted stock units
@ $0 |
|
| 09/08/2020 |
4
| Rolfe Lindsey (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Sold 299 shares
@ $5.3, valued at
$1.6k
Sold 329 shares
@ $5.3, valued at
$1.7k
Exercised 625 restricted stock units
@ $0
Exercised 688 restricted stock units
@ $0 |
|
| 08/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Rolfe Lindsey (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Sold 1,728 shares
@ $6.74, valued at
$11.6k
Exercised 3,438 restricted stock units
@ $0 |
|
| 06/15/2020 |
4
| Rolfe Lindsey (Director) has filed a Form 4 on Atreca, Inc.|
Txns:
| Granted 12,000 options to buy
@ $17.87, valued at
$214.4k
|
|
| 06/05/2020 |
4
| Rolfe Lindsey (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Sold 324 shares
@ $7.03, valued at
$2.3k
Sold 356 shares
@ $7.03, valued at
$2.5k
Exercised 625 restricted stock units
@ $0
Exercised 687 restricted stock units
@ $0 |
|
| 05/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2020 |
4
| Rolfe Lindsey (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Paid exercise price by delivering 16,733 shares
@ $6.8, valued at
$113.8k
Exercised 23,034 options to buy
@ $3.08, valued at
$70.9k
|
|
| 03/23/2020 |
4
| Rolfe Lindsey (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Sold 1,728 shares
@ $4.6, valued at
$7.9k
Exercised 3,437 restricted stock units
@ $0 |
|
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2020 |
4
| Rolfe Lindsey (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Sold 7,503 shares
@ $8.41, valued at
$63.1k
Exercised 14,997 restricted stock units
@ $0 |
|
| 01/31/2020 |
4
| Rolfe Lindsey (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 74,000 restricted stock units
@ $0 |
|
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|